速递|砸下4.32亿欧元,诺和诺德把口服减肥药的产能押在爱尔兰

GLP1减重宝典
Mar 02

整理 | GLP1减重宝典内容团队3月2日,诺和诺德宣布将投资4.32亿欧元(约5.06亿美元),扩建并改造其位于爱尔兰阿斯隆 Athlone(Monksland)的口服制剂工厂,为当前和未来的口服GLP-1治疗药物新增制造能力。该项目已启动建设,工厂现有约260名员工将继续在升级后的设施内生产口服药物;扩建覆盖约45英亩(约18公顷)用地,施工高峰期预计带来最多500个建筑岗位,并计划在2027...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10